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Cryptococcus neoformans is an opportunistic fungal pathogen that primarily causes disease in immunocom-
promised individuals. Dendritic cells (DCs) can phagocytose C. neoformans, present cryptococcal antigen, and
kill C. neoformans. However, early events following C. neoformans phagocytosis by DCs are not well defined. We
hypothesized that C. neoformans traffics to the endosome and the lysosome following phagocytosis by DCs and
is eventually killed in the lysosome. Murine bone marrow-derived DCs (BMDCs) or human monocyte-derived
DCs (HDCs) were incubated with live, encapsulated C. neoformans yeast cells and opsonizing antibody.
Following incubation, DCs were intracellularly stained with antibodies against EEA1 (endosome) and LAMP-1
(late endosome/lysosome). As assessed by confocal microscopy, C. neoformans trafficked to endosomal com-
partments of DCs within 10 min and to lysosomal compartments within 30 min postincubation. For HDCs, the
studies were repeated using complement-sufficient autologous plasma for the opsonization of C. neoformans.
These data showed results similar to those for antibody opsonization, with C. neoformans localized to endo-
somes within 20 min and to lysosomes within 60 min postincubation. Additionally, the results of live real-time
imaging studies demonstrated that C. neoformans entered lysosomal compartments within 20 min following the
initiation of phagocytosis. The results of scanning and transmission electron microscopy demonstrated con-
ventional zipper phagocytosis of C. neoformans by DCs. Finally, lysosomal extracts were purified from BMDCs
and incubated with C. neoformans to determine their potential to kill C. neoformans. The extracts killed C.
neoformans in a dose-dependent manner. This study shows that C. neoformans enters into endosomal and
lysosomal pathways following DC phagocytosis and can be killed by lysosomal components.
Cryptococcus neoformans is an opportunistic fungal patho-
gen that causes disease predominantly in immunocompro-
mised patients, particularly individuals with AIDS, transplant
recipients, and those with lymphoid and hematological malig-
nancies (25, 35, 47, 49). Protective immunity to C. neoformans
is dependent on an adaptive Th1-type immune response (18–
21, 36, 37). Dendritic cells (DCs) are important in the presen-
tation of foreign antigens to T cells in the lymphoid tissues and
the initiation of an adaptive immune response against these
antigens (3, 34, 48, 56). The results of previous studies by our
laboratory have shown that DCs have the capacity to phago-
cytose C. neoformans in vitro by a process which requires
opsonization with either complement or antibody (22). Follow-
ing phagocytosis, DCs are capable of antifungal activity against
C. neoformans (22). In addition, we have shown that C. neo-
formans can be phagocytosed by DCs in vivo following pulmo-
nary inoculation (59), which leads to DC maturation and an-
tigen presentation to Cryptococcus-specific T cells.
Phagocytosis of infectious organisms begins with binding of
the organism to the cell, formation of an endocytic vesicle
(phagosome), maturation of the phagosome into a phagolyso-
some, and eventual digestion within the phagosome (reviewed
in reference 52). DCs phagocytose organisms and process
them via the endocytic pathway for presentation by major
histocompatibility complex class II (MHC-II) (41, 53). The
maturation of the endocytic compartment is dependent on
fusion to the late endosome or lysosome, and once phagocy-
tosed cargo reaches the lysosome, a combination of reactive
oxygen and nitrogen intermediates, acidic pH, and cathepsin
hydrolytic enzyme activities can contribute to killing, degrada-
tion, and proteolysis (9, 12, 32, 53, 54, 55). In addition, endo-
somes and lysosomes function as storage and antigen-loading
compartments for MHC-II (16, 31). Following the degradation
of phagocytosed microbial pathogens, microbial antigens can
be targeted to the MHC-II pathway for presentation to T cells
(4, 23, 34, 60).
As mentioned earlier, one consequence of lysosomal entry is
that enzymatic action can kill phagocytosed organisms. For the
fungus Histoplasma capsulatum, phagolysosomal fusion can
lead to the killing and degradation of phagocytosed organisms
by DCs (17). DC killing of fungal pathogens can proceed by
oxidative and/or nonoxidative mechanisms. Thus, human DCs
(HDCs) can kill phagocytosed Candida albicans in the absence
of superoxide or nitric oxide (38), while mouse DCs kill C.
albicans yeasts following recognition by the mannose-fucose
receptor and the release of nitric oxide and inducible nitric
oxide synthase (14).
Following phagocytosis of C. neoformans by murine DCs,
the fungus has been shown to colocalize with CD63-positive
compartments (2). CD63, also known as LAMP-3, is a tet-
raspanin that is also a marker of endosomes and lysosomes.
CD63 interacts with MHC-II during antigen presentation and
may chaperone MHC-II through the endosomal pathway and
be involved in the recycling of MHC-II (43, 58). However, the
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entry into early endosomes of DCs and DC lysosomal degra-
dation of C. neoformans have not been explored. We hypoth-
esized that following phagocytosis by DCs, C. neoformans en-
ters the endosomal/lysosomal pathway, where it is killed and
degraded for antigen presentation to T cells. Therefore, in the
present studies, we determined the intracellular location of C.
neoformans organisms following phagocytosis by murine DCs
and HDCs. Moreover, we examined the capacity of lysosomes
isolated from DCs to kill C. neoformans.
MATERIALS AND METHODS
Reagents. Unless otherwise stated, chemical reagents of the highest quality
available were obtained from Sigma-Aldrich Co. (St. Louis, MO), tissue culture
media were purchased from Gibco Life Technologies (Rockville, MD), and
plasticware was purchased from Fisher Scientific (Pittsburgh, PA). The medium
used in murine bone marrow-derived DC (BMDC) experiments was RPMI 1640
supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine,
100 U penicillin/ml, 100 g of streptomycin/ml, and 50 mM 2-mercaptoethanol
(complete medium). The medium used in HDC experiments was RPMI 1640
supplemented with 5% heat-inactivated fetal bovine serum, 2 mM L-glutamine,
100 U penicillin/ml, 100 g of streptomycin/ml, 50 mM 2-mercaptoethanol, and
10 mM HEPES (HDC medium). All cell culture incubations were performed at
37°C in a humidified environment supplemented with 5% CO2.
Culture of Cryptococcus. Cryptococcus neoformans serotype A encapsulated
strain 145 (ATCC 62070; American Type Culture Collection, Manassas, VA) was
cultured for 24 h at 30°C in yeast extract-peptone-dextrose plus 2% glucose. Live
C. neoformans organisms were washed with sterile phosphate-buffered saline
(PBS), counted, and resuspended in sterile PBS to the concentration needed for
each experiment.
Fluorescent labeling of Cryptococcus. Live C. neoformans organisms were
washed with sterile 0.1 M sodium bicarbonate buffer, pH 8.0 (staining buffer),
counted, and resuspended to 5 108/ml. C. neoformans yeast was incubated with
2 g/ml Oregon green 488 (Molecular Probes, Eugene, OR) at room tempera-
ture in the dark for 1 h. The organisms were then washed three times with sterile
PBS, counted, and resuspended in sterile PBS to the concentration needed for
each experiment.
Fluorescent labeling of 3C2 antibody. Opsonizing anti-capsular monoclonal
3C2 antibody (gift of Thomas Kozel, University of Nevada, Reno, NV) (50) was
diluted in staining buffer to 100 g/ml. Oregon green 488 was added at 100
g/ml, and the mixture was incubated at room temperature in the dark for 1 h.
The antibody was separated from excess dye by using a Sephadex G-25 column.
BMDCs. C57BL/6 mice were purchased from Jackson Laboratory (Bar Har-
bor, ME) and were housed under pathogen-free conditions in microisolator
cages according to institutionally recommended guidelines at the University of
Massachusetts Medical School Department of Animal Medicine. BMDC culture
was performed as previously described (22, 30). Briefly, bone marrow was flushed
from the femurs and tibiae of C57BL/6 mice. Cells were washed, counted, and
plated in complete medium supplemented with 10% filter-sterilized supernatant
from the J558L cell line (which constitutively produces granulocyte-macrophage
colony-stimulating factor) (39). One half of the medium was replaced every three
days, and the cells were harvested on day 8 or 9 following plating. The cells were
then purified by positive selection using magnetically labeled CD11c antibodies
(Miltenyi Biotec, Auburn, CA).
HDCs. Monocyte-derived HDCs were obtained as described previously (44).
Briefly, peripheral blood was obtained from healthy volunteers by venipuncture
following informed consent, using a protocol approved by the University of
Massachusetts Medical School Institutional Review Board. The blood was anti-
coagulated with heparin (American Pharmaceutical Partners, Inc., Los Angeles,
CA) and diluted 1:1 with Hank’s balanced salt solution (BioWhittaker, Walk-
ersville, MD). Peripheral blood mononuclear cells (PBMCs) were purified in a
Leukosep tube (Greiner Bio-One, Germany) over a Lymphoprep gradient (Ac-
curate Chemical & Scientific Corp., Westbury, NY). The tubes were centrifuged
at 1,000  g for 10 min without the brake. After separation, the autologous
diluted plasma was collected and stored at20°C until use. The PBMC layer was
isolated and washed three times with HDC medium. PBMCs (1  105 to 3 
105/well) were added to a six-well tissue culture plate for 2 h at 37°C to allow
monocyte adherence and then gently washed to remove nonadherent cells.
HDCs were cultured for 7 days with 50 ng/ml recombinant human interleukin-4
(Peprotech, Rocky Hill, NJ) and 150 ng/ml recombinant human granulocyte-
macrophage colony-stimulating factor (sargramostim; Bayer, Wayne, NJ). The
cells were then positively selected for CD1c (BDCA-1) expression by using
magnetically labeled CD1c antibodies (Miltenyi Biotec).
DC phagocytosis of C. neoformans. BMDCs or HDCs were harvested, purified,
and counted. DCs and C. neoformans organisms were incubated at a 2:1 ratio in
the presence of 1 g/ml of Oregon green-stained 3C2 opsonizing antibody for 10,
20, 30, or 60 min at 37°C in 1.7-ml microcentrifuge tubes (Costar, Corning, NY).
For phagocytosis with plasma opsonins, HDCs were incubated with Oregon
green-labeled Cryptococcus in the presence of autologous human plasma.
Intracellular staining. Following incubation of DCs and C. neoformans organ-
isms, DCs were fixed with 2% paraformaldehyde in PBS for 10 min at room
temperature. After fixation, the cells were washed and permeabilized with 0.1%
saponin for 10 min at room temperature. While permeabilized, the cells were
intracellularly stained with either anti-EEA1 (ABR Affinity Bioreagents,
Golden, CO) or anti-LAMP-1 (mouse; eBioscience, San Diego, CA, or human;
Santa Cruz Biotechnology, Santa Cruz, CA). For both BMDCs and HDCs,
purified anti-EEA1 was the primary antibody and was followed by anti-rabbit
immunoglobulin G (IgG) conjugated to Alexa 568 (Molecular Probes). For
BMDCs, biotinylated LAMP-1 was used, followed by streptavidin-Alexa 568
(Molecular Probes). For HDCs, purified LAMP-1 was the primary antibody and
was followed by anti-rabbit IgG conjugated to Alexa 568 (Molecular Probes).
Control antibodies matched for species and isotype were used for each experi-
ment as follows: for EEA1, rabbit IgG (Sigma); for human LAMP-1, mouse IgG1
(eBioscience); and for murine LAMP-1, rat IgG2a (eBioscience). Phagocytosis
was defined as the detection of the presence of intracellular C. neoformans
organisms by confocal microscopy. The intracellular location of the C. neofor-
mans yeast cells was confirmed by z-stack images. Confocal imaging was per-
formed on a Leica TCS SP2 inverted confocal microscope (Leica Microsystems,
Wetzlar, Germany), and Leica confocal software (LCS) was used for the acqui-
sition of images. The images were viewed using a 63, 1.40-numerical-aperture
oil-immersion Leica lens and were digitally increased in size fourfold by using
LCS. Fusion with endosomes or lysosomes was determined by the visualization
of C. neoformans organisms within the stained compartments.
Live imaging of phagocytosis. BMDCs were harvested, purified, and incubated
with C. neoformans yeast cells at a 2:1 ratio in the presence of 1 g/ml of Oregon
green-labeled 3C2 antibody and 50 nM LysoTracker red (Molecular Probes).
Samples were placed on ice until live imaging by confocal microscopy. For
imaging, the sample was placed in a glass-bottomed, 35-mm culture dish (Mat-
Tek Corp., Ashland, MA) on a stage heated to 37°C. Once the interaction of DCs
with C. neoformans was observed, confocal images were obtained every 30 s in
order to determine whether entry of C. neoformans into the stained lysosomal
compartment occurred.
Examination of phagocytosis by electron microscopy. BMDCs were harvested,
purified, and incubated with C. neoformans yeast cells at a 2:1 ratio in the
presence of 1 g/ml 3C2 opsonizing antibody for 10, 20, 30, 40, 50, or 60 min.
Following incubation, cells were fixed with 2.5% glutaraldehyde and processed
for transmission electron microscopy (TEM) or scanning electron microscopy
(SEM). Following sample preparation, cells were examined on a Philips CM10
TEM for the presence of C. neoformans in intracellular compartments. For SEM,
cells were examined on an FEI Quanta 200 FEG MKII SEM for the uptake of
C. neoformans by DCs.
Lysosomal extract purification from DCs. BMDCs were cultured, harvested,
and purified as described above. Crude lysosomal extracts were obtained (S. L.
Newman and W. Lemen, unpublished data). Briefly, 1 lysosomal extraction
buffer (Sigma-Aldrich) was added at 2.7 ml per 3  108 cells. DCs were homog-
enized with a PowerGen 700 homogenizer (Fisher Scientific, Pittsburgh, PA)
using a 7- by 110-mm homogenizer tip (Fisher Scientific). The homogenizer was
passed through the cells 20 to 25 times (which disrupted 75 to 80% of the cells),
and then cells were centrifuged for 10 min at 1,000 g to remove intact cells and
cellular debris. The supernatants were collected and centrifuged for 20 min at
20,000  g to pellet lysosomes. The supernatants were discarded, and the pellet
containing the lysosomes was resuspended in 1 ml of 1 extraction buffer. The
sample was then sonicated for 20 s at a setting of 40% on a model 500 Sonic
Dismembrator (Fisher Scientific). The resultant product following sonication
was the crude lysosomal extract.
Lysosomal killing of C. neoformans. C. neoformans killing assays were per-
formed as previously described (28, 33, 42). Briefly, following culture of encap-
sulated C. neoformans yeast cells, the organisms were washed three times with
sterile PBS and resuspended in 10 mM phosphate buffer with 2% RPMI 1640,
pH 5.5 (lysosomal buffer). The fungi were then added to 96-well plates in a
volume of 50 l (2.5  105/ml). Lysosomal extracts were added at 10, 25, and
50%, and the wells were filled with lysosomal buffer to a total volume of 100 l.
The plates were then incubated for 24 h at 37°C. Following incubation, the
organisms were diluted in sterile PBS and plated on Sabouraud dextrose agar
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plates. The plates were incubated at room temperature for 3 days, and then CFU
were counted.
Statistical analysis. For statistical comparisons, we utilized one-way analysis of
variance with Tukey’s multiple correction test. P values of0.05 were considered
significant. The data were analyzed by using GraphPad Prism software (Graph-
Pad Software, Inc., San Diego, CA).
RESULTS
Intracellular trafficking of C. neoformans yeast following
phagocytosis by DCs. In order to determine the intracellular
location of C. neoformans yeast cells following phagocytosis
by DCs, BMDCs and HDCs were incubated with C. neofor-
mans. The DCs were then fixed, intracellularly stained with
antibodies for EEA1 (early endosomes) or LAMP-1 (late
endosomes/lysosomes), and examined by confocal micros-
copy. The results showed that for both BMDCs and HDCs,
more than half of the C. neoformans-containing phagosomes
had fused with EEA1-positive compartments by 10 min
postincubation (Fig. 1A). By 20 min postincubation, the
majority of C. neoformans-containing phagosomes had fused
with EEA1-positive compartments, and this remained con-
stant through 60 min postincubation. LAMP-1-positive com-
partments fused with few C. neoformans-containing phago-
somes at early time points, but the majority had fused by 30
min postincubation and continued to be fused through 60
min postincubation (Fig. 1).
Live imaging of C. neoformans phagocytosis by DCs. Al-
though the data from the intracellular staining confirmed the
entry of C. neoformans organisms into endosomes and lyso-
somes, those experiments were timed from the beginning of
the incubation, not the beginning of phagocytosis. In order to
determine how quickly entry into lysosomes occurred following
contact and phagocytosis, live confocal imaging was per-
formed. The results showed that the majority of C. neoformans
organisms appeared to enter the lysosomal compartment of
FIG. 1. Localization of C. neoformans to early endosomes and lysosomes following phagocytosis by murine DCs. Murine DCs were purified and
incubated with encapsulated C. neoformans cells and Oregon green 488-labeled opsonizing antibody. DCs were then fixed, permeabilized, and
stained with anti-EEA1 antibody (Alexa 568) or anti-LAMP-1 antibody (Alexa 568). Cells were imaged by confocal microscopy. (A) Line graph
of average percentages of C. neoformans organisms inside EEA1- and LAMP-1-positive compartments of DCs following phagocytosis at 10, 20,
30, and 60 min postincubation. Data shown are representative of the results of six to eight independent experiments performed with BMDCs and
three independent experiments performed with HDCs. Three to four images (including z-stack images) were obtained for each time point.
(B) Representative confocal images of C. neoformans organisms in EEA1-positive compartments at 20 min postincubation. The arrows (in the red
and green merged image) point to the two C. neoformans organisms in EEA1-positive compartments. (C) Representative confocal images of C.
neoformans organisms shown in LAMP-1-positive compartments at 60 min postincubation. Scale bar 11.9 m. In panels B and C, “Merge” panels
at far right show merged images of bright-field, red, and green panels.
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BMDCs (stained with LysoTracker red) within 20 min follow-
ing uptake (Fig. 2; see Fig. S2 in the supplemental material).
Cryptococcus trafficking following opsonization with comple-
ment-sufficient plasma. In natural human infections, anticryp-
tococcal antibodies may be absent or complexed with shed
capsule. In those situations, binding and phagocytosis are de-
pendent upon complement opsonization (22, 26, 51). Phago-
cytosis by complement- and Ig-opsonized organisms proceeds
by different receptors (complement receptors and Fc recep-
tors, respectively) (4). Therefore, we next determined the in-
tracellular fate of C. neoformans in DCs following opsonization
with complement-sufficient autologous human plasma. HDCs
were incubated with C. neoformans yeast and autologous
plasma, and then the DCs were intracellularly stained with
EEA1 or LAMP-1 and examined by confocal microscopy (Fig.
3). The results showed that the C. neoformans-containing
phagosomes had fused with EEA1-positive compartments by
20 min postincubation and remained fused through 60 min
postincubation. The majority of C. neoformans-containing
phagosomes had fused with LAMP-1-positive compartments
by 30 min postincubation and continued to be fused when
observed at 60 min postincubation.
Electron microscopy of internalized C. neoformans organ-
isms in DCs. Phagocytosis of microorganisms by DCs can
proceed by conventional (“zipper”) or “coiling” mechanisms
(6–8, 14, 40). To determine how DC phagocytosis of C. neo-
formans proceeded and to confirm that C. neoformans was
indeed found within intracellular compartments of the DCs,
SEM and TEM were performed following the incubation of
BMDCs with C. neoformans yeast (Fig. 4). By 10 min, the
earliest time point examined, C. neoformans yeast cells were
observed in the process of being internalized by conventional
phagocytosis (Fig. 4A to D). Coiling phagocytosis was not
observed. In addition, the TEM images demonstrated that fully
phagocytosed C. neoformans organisms were surrounded by
intact membranes that abutted the organisms’ capsules (Fig.
4D to F).
Fungicidal activity of DC-derived lysosomal extract against
C. neoformans. The results of the above studies demonstrated
fusion of C. neoformans organisms with DC lysosomes. As the
results of previous studies demonstrated that DCs kill C. neo-
formans (22), we next sought to determine whether lysosomes
had direct antifungal activity. Lysosomes were isolated from
DCs and disrupted by sonication. This crude lysosomal extract,
isolated from 3  108 cells per ml, contained 1,000 to 1,250 mg
protein and 6 to 10 units of acid phosphatase activity (a marker
of lysosomal activity) per ml. In addition, prior to sonication,
the crude lysosomes stained positively for LAMP-1 by confocal
microscopy. The extract was incubated with C. neoformans
yeast for 24 h, following which the numbers of CFU were
determined. The lysosomal extracts had dose-dependent anti-
fungal activity (Fig. 5). The inoculum was almost completely
killed following the incubation of C. neoformans with 50%
lysosomal extract added.
DISCUSSION
DCs have been shown to be involved in the phagocytosis of
C. neoformans both in vivo and in vitro (22, 59). Phagocytosis
and the subsequent intracellular events are critical factors de-
termining the fate of the pathogen and the cell-mediated im-
mune response. Previous data from our laboratory showed that
pulmonary DCs exposed to C. neoformans yeast in vivo were
able to present cryptococcal antigens to antigen-specific T cells
ex vivo (59). In addition, BMDCs and HDCs kill complement-
and antibody-opsonized C. neoformans organisms in vitro (22).
Based on these data, we hypothesized that, following DC
phagocytosis, C. neoformans traffics to endosomal and lysoso-
mal compartments, where it is ultimately killed.
To determine where the C. neoformans organisms localized
following DC phagocytosis, we incubated DCs with anticapsu-
lar antibody and C. neoformans yeast and examined fusion with
the endosome (EEA-1) and late endosome/lysosome (LAMP-
1). In human monocyte-derived macrophages, C. neoformans
yeast has been shown to localize to LAMP-1-positive compart-
ments and survive this acidic environment (29). In addition, C.
neoformans can colocalize with CD63-positive compartments
in immature murine DCs (2). In our current confocal micros-
copy studies, in both murine DCs and HDCs, phagocytosed C.
neoformans organisms trafficked to endocytic compartments
within 10 to 20 min and to lysosomal compartments within 30
to 60 min following fungal challenge. These findings correlated
well with the results of studies of endosomal and lysosomal
localization of soluble antigens that demonstrate that endoso-
mal entry occurred between 2.5 and 10 min postuptake and
lysosomal entry between 30 and 60 min postuptake (45).
Phagocytosis of organisms by DCs can proceed via different
mechanisms, including the conventional zipper-type mecha-
FIG. 2. Live imaging of DC phagocytosis of C. neoformans organisms and phagolysosomal fusion. Murine DCs were incubated with encap-
sulated C. neoformans cells, Oregon green 488-labeled opsonizing antibody, and LysoTracker red. Live cells were examined by confocal microscopy
at 37°C, with the zero-minute time point indicative of when phagocytosis commenced. Images shown are representative of 10 observations of
BMDCs phagocytosing C. neoformans cells. In 8 out of 10 of these observations, including the one shown in the figure, C. neoformans yeast was
found in LysoTracker red-positive (lysosomal) compartments within 20 min following phagocytosis. Scale bar  11.9 m.
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nism and coiling phagocytosis (6–8, 40). In order to examine
the mechanisms by which DCs phagocytose C. neoformans, we
performed TEM and SEM. DC phagocytosis of C. neoformans
appeared to proceed through the conventional zipper-type
phagocytosis mechanism, as evidenced by the presence of sym-
metrical pseudopods and nonoverlapping pseudopods. No ev-
idence of coiling phagocytosis was observed. In addition, the
results of TEM confirmed that phagocytosed C. neoformans
organisms were indeed inside membrane-bound compartments
of DCs.
Vaccination strategies designed to elicit anticapsular anti-
bodies and passive antibody administration represent promis-
ing strategies for the prevention and treatment, respectively, of
cryptococcosis (reviewed in references 10 and 11). However,
the results of studies demonstrating that phagocytosis of C.
neoformans yeast by HDCs is dependent upon heat-labile se-
rum opsonins strongly suggest a predominant role for comple-
ment in phagocytosis (22). As the specific receptors mediating
uptake can be critical determinants of subsequent intracellular
trafficking events (reviewed in reference 4), it was important to
determine whether the fate of C. neoformans differed depend-
ing upon whether entry was via complement or Fc receptors.
We found that C. neoformans trafficked into the endosome and
then into the lysosome regardless of whether opsonization was
with complement-sufficient plasma or antibody. In contrast,
recent data from examining the interaction of C. albicans with
DCs found that the fate of the fungus was linked to the recep-
tor mediating uptake. Thus, entry via dectin-1 resulted in fun-
gal killing by stimulating NAPDH oxidase activity, whereas C.
albicans could escape the oxidative damage by entering DCs
through receptors not involved in NADPH oxidase activation,
such as the mannose receptor, CD206 (13).
Our studies focused on early time points, and it remains
possible that surviving organisms could escape the phagolyso-
some at later time points. While C. neoformans can be killed by
DCs (22) and by macrophages (5, 27, 28), under some condi-
tions, C. neoformans has also been shown to survive the
phagolysosome of macrophages (29). Several mechanisms have
FIG. 3. Localization of C. neoformans to early endosomes and lysosomes following serum opsonization and phagocytosis by HDCs. HDCs were
incubated with encapsulated C. neoformans in the presence of complement-sufficient autologous plasma. Following incubation, HDCs were fixed,
permeabilized, and stained with anti-EEA1 antibody (Alexa 568) or anti-LAMP-1 antibody (Alexa 568). (A) Line graph of average percentages
of C. neoformans organisms inside EEA1- and LAMP-1-positive compartments of HDCs following phagocytosis at 10, 20, 30, and 60 min
postincubation. These data are from three independent experiments. Three to four images (including z-stack images) were obtained at each time
point. (B) Representative confocal images of C. neoformans organisms in EEA1-positive compartments at 20 min postincubation. (C) Represen-
tative confocal images of C. neoformans organisms in LAMP-1-positive compartments at 30 min postincubation. Scale bar  11.9 m. In panels
B and C, “Merge” panels at far right show merged images of bright-field, red, and green panels.
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been described for macrophages by which C. neoformans can
escape the phagosome and even the phagocyte. C. neoformans
can produce phospholipases that cause phagolysosomal mem-
brane permeability, which can lead to the dissemination of the
organism (46). In addition, growth, either by capsular expan-
sion or budding, could mechanically disrupt the membrane.
Further, recent data have shown that C. neoformans can exit
from macrophages via extrusion of the phagosome (1).
Whether such escape mechanisms exist for C. neoformans in
DCs is not known.
Mechanisms have been described by which microbial patho-
gens escape killing and degradation by the lysosome of DCs.
For example, Mycobacterium tuberculosis can translocate from
phagolysosomes to the cytosol of DCs, thus escaping killing and
degradation (57). At certain stages of its life cycle, Leishmania
major resides in DC endocytic compartments where it can escape
lysosomal killing by blocking the fusion of lysosomes (24). Salmo-
nella enterica serovar Typhimurium is found in DC compartments
that lack lysosomal markers, suggesting that this organism pre-
FIG. 4. Results of electron microscopy of C. neoformans phagocytosis by DCs. Following culture, BMDCs were purified and incubated for
specified times with encapsulated C. neoformans cells and opsonizing antibody. DCs were then fixed and examined by SEM or TEM. (A) SEM of
two C. neoformans yeast cells shown in the process of being phagocytosed by a DC at 10 min postincubation. Arrow points to a pseudopod from
the DC attached to the yeast cell. Original magnification,19,000. Scale bar 4 m. (B) SEM of two C. neoformans yeast cells being phagocytosed
by a DC at 10 min postincubation. Original magnification,16,000. Scale bar 5 m. (C) Close-up of the boxed area from panel B demonstrating
a C. neoformans yeast cell partially covered by the “flap” of a DC pseudopod (arrow). Original magnification,50,000. Scale bar 1 m. (D) One
C. neoformans yeast cell is seen inside a membrane-bound compartment of a DC, while another is just beginning to be phagocytosed (arrow) at
50 min postincubation. Original magnification, 7,100. Scale bar  2 m. (E) A C. neoformans yeast cell is seen inside a membrane-bound
compartment of a DC at 20 min postincubation. Original magnification, 19,500. Scale bar  0.5 m. (F) Close-up of the boxed area from panel
E demonstrating a C. neoformans cell surrounded by a contiguous endosomal membrane (arrows). Original magnification, 40,000. Scale bar 
200 nm.
FIG. 5. Killing of C. neoformans by lysosomal extracts from BMDCs.
C. neoformans yeast cells were incubated in lysosomal buffer with the
indicated concentrations of lysosomal extracts for 24 h at 37°C, following
which the numbers of CFU in the wells were determined as described in
Materials and Methods. The numbers of CFU in the inoculum are also
shown. Data shown are means  standard errors of the means of the
results of four independent experiments, with each condition performed
in duplicate. An asterisk indicates a significant difference compared to the
results for 0% extract (P  0.0001).
VOL. 76, 2008 INTRACELLULAR FATE OF C. NEOFORMANS IN DENDRITIC CELLS 4769
 at UNIV O
F M
ASS M
ED SCH on Novem
ber 27, 2009 
iai.asm
.org
D
ow
nloaded from
 
vents phagolysosomal fusion (15). However, based on the results
of the studies presented herein, at least in the first hour following
phagocytosis, C. neoformans yeast localizes to and remains in the
endosomal and lysosomal compartments of DCs.
DC killing of fungi can proceed by oxidative and/or nonoxi-
dative mechanisms. Antifungal activity against C. neoformans
was partially reduced in the presence of respiratory burst in-
hibitors, suggesting roles for both oxidative and nonoxidative
systems (22). However, inhibitors of the respiratory burst did
not affect the ability of HDCs to kill phagocytosed C. albicans
or H. capsulatum (17, 38). Moreover, the addition of suramin,
an inhibitor of phagosome-lysosome fusion, to Histoplasma-
infected DCs inhibited phagosome-lysosome fusion and DC
fungicidal activity (17). Lysosomal killing and degradation by
DCs could be important for both pathogen clearance and
MHC-restricted antigen presentation to naı¨ve T cells. There-
fore, we determined whether lysosomal components from DCs
were capable of killing C. neoformans. We found that crude
lysosomal extracts from DCs had dose-dependent anticrypto-
coccal activity, with nearly complete killing observed when the
extracts were diluted 50%. Current studies in our laboratory
are focused on determining the antifungal effectors in DC
lysosomes that are responsible for killing C. neoformans. For
human neutrophils, multiple peptides and proteins, including
defensins, have been shown to kill C. neoformans (33).
In summary, we have shown that C. neoformans traffics into
the endosomal and lysosomal compartments of HDCs and
murine DCs following phagocytosis. In addition, this trafficking
was independent of the method of opsonization, suggesting
that multiple mechanisms exist for the entry of phagocytosed
organisms into the endosomal pathway. Moreover, we have
shown that purified lysosomal components of DCs are able to
kill C. neoformans. Based on the data presented herein, we
suggest that the intracellular trafficking and delivery of C. neo-
formans organisms to the lysosome for degradation may be
important in the antigen presentation of cryptococcal antigens
to T cells. DCs play a key role in the host defense against
several pathogenic microorganisms by initiating adaptive cell-
mediated immune responses. Understanding the interaction of
DCs and their lysosomal components with C. neoformans yeast
will help in gaining insights into its pathogenesis and may also
lead to the development of innovative immunotherapies to
help control cryptococcal infection.
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